$2.610
+0.104 (+3.98%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Rocket Pharmaceuticals Inc (RCKT) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting RCKT is Sell.
Rocket Pharmaceuticals Inc (RCKT) 20-Day simple moving average is 2.40, while Rocket Pharmaceuticals Inc (RCKT) share price is $—, making it Buy.
Rocket Pharmaceuticals Inc (RCKT) 60-Day simple moving average is 3.00, while Rocket Pharmaceuticals Inc (RCKT) share price is $—, making it Sell.
Technical Analysis for RCKT
AI Technical RCKTAs of 2026-11-03, the technical board for Rocket Pharmaceuticals Inc (RCKT) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $2.61 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 52.417, MACD stands at -0.0777 (Sell), Stochastic %K stands at 72.277, Stochastic %D stands at 65.457 and CCI stands at 95.92.
RCKT trades below the 60-day SMA (3.00) and below the 200-day SMA (3.43). Immediate resistance sits at Classic R1 2.69, then R2 2.93. Support sits at Classic S1 2.19, then S2 1.93.
Rocket Pharmaceuticals Inc (RCKT) Support & Resistance Level
Rocket Pharmaceuticals Inc (RCKT) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 52.417 |
| STOCHk_14_3_3 | 72.277 |
| STOCHd_14_3_3 | 65.457 |
| CCI_20 | 95.920 |
| AO_5_34 | -0.055 |
| MOM_10 | 0.410 |
| MACD_12_26_9 | -0.078 |
Rocket Pharmaceuticals Inc (RCKT) Relative Strength Index (RSI_14) is 52.417, creating a Neutral signal.
Rocket Pharmaceuticals Inc (RCKT) Stochastic %K is 72.277, creating a Neutral signal.
Rocket Pharmaceuticals Inc (RCKT) Stochastic %D is 65.457, creating a Neutral signal.
Rocket Pharmaceuticals Inc (RCKT) CCI_20 is 95.920, creating a Neutral signal.
Rocket Pharmaceuticals Inc (RCKT) Awesome Oscillator (AO) is -0.055, creating a Sell signal.
Rocket Pharmaceuticals Inc (RCKT) Momentum (MOM) is 0.410, creating a Buy signal.
Rocket Pharmaceuticals Inc (RCKT) Moving Average Convergence Divergence (MACD) is -0.078, creating a Sell signal.
Rocket Pharmaceuticals Inc (RCKT) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.514 | Buy |
| MA_10 | 2.448 | Buy |
| MA_20 | 2.399 | Buy |
| MA_60 | 2.998 | Sell |
| MA_200 | 3.434 | Sell |
| MA_250 | 3.422 | Sell |
Rocket Pharmaceuticals Inc (RCKT) 5-Day simple moving average is 2.514, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Buy.
Rocket Pharmaceuticals Inc (RCKT) 10-Day simple moving average is 2.448, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Buy.
Rocket Pharmaceuticals Inc (RCKT) 20-Day simple moving average is 2.399, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Buy.
Rocket Pharmaceuticals Inc (RCKT) 60-Day simple moving average is 2.998, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Sell.
Rocket Pharmaceuticals Inc (RCKT) 200-Day simple moving average is 3.434, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Sell.
Rocket Pharmaceuticals Inc (RCKT) 250-Day simple moving average is 3.422, while Rocket Pharmaceuticals Inc (RCKT) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.